Substance use among adolescents and young adults with chronic kidney disease or kidney failure
Authors:
- 9 March 2021
- journal article
- review article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 36 (11) , 3585-3593
Abstract
Substance use, a significant public health issue, is well described in the adult chronic kidney disease (CKD) population. Knowledge about substance use in the adolescent and young adult (AYA) CKD population such as prevalence, impact on kidney function, medication adherence, and psychosocial well-being remain largely unknown. Awareness of and inquiring about substance use is paramount to providing evidence-based care and preparation to transition to adult-focused health services. The authors in this review identify commonly used substances (alcohol, tobacco, marijuana, etc.) and how they impact kidney function and care of the AYA with CKD or kidney failure. Recommendations for screening and intervention strategies are provided.Keywords
This publication has 87 references indexed in Scilit:
- Secondhand smoke exposure is associated with proteinuria in children with chronic kidney diseasePediatric Nephrology, 2013
- Comparison of (+)‐methamphetamine, ±‐Methylenedioxymethamphetamine, (+)‐amphetamine and ±‐fenfluramine in rats on egocentric learning in the Cincinnati water mazeSynapse, 2010
- Cigarette Smoking and Progression of IgA NephropathyAmerican Journal of Kidney Diseases, 2010
- Opioid MetabolismMayo Clinic Proceedings, 2009
- Prevalence of and Associations with Waterpipe Tobacco Smoking among U.S. University StudentsAnnals of Behavioral Medicine, 2008
- Cigarette smoking and chronic allograft nephropathyNephrology Dialysis Transplantation, 2007
- Renal amyloidosis in intravenous drug usersQJM: An International Journal of Medicine, 2006
- Chronic Nephropathies of Cocaine and Heroin AbuseClinical Journal of the American Society of Nephrology, 2006
- Necrotizing renal vasculopathy resulting in chronic renal failure after ingestion of methamphetamine and 3,4-methylenedioxymethamphetamine ('ecstasy')Nephrology Dialysis Transplantation, 1998
- 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humansAddiction, 1994